Vivoryon Therapeutics N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
11 mei 2016 - 11:04
Statutaire naam
Vivoryon Therapeutics N.V.
Titel
Probiodrug to Present at the 1st Meeting of The Society for CSF analysis and Clinical Neurochemistry
Bericht
Probiodrug to Present at the 1st Meeting of
The Society for CSF analysis and Clinical Neurochemistry
HALLE/SAALE, Germany, 11 May 2016 - Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer's disease (AD), announces today that two posters will be presented at the 1st Meeting of the newly founded Society for CSF Analysis and Clinical Neurochemistry in Gothenburg, Sweden. The first general meeting will be held from 12 - 13 May, 2016 at the University of Gothenburg.
The posters being presented are entitled:
Gerelateerde downloads
Datum laatste update: 09 mei 2025